UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of January 2026
Commission
File Number: 001-42915
Alps
Group Inc
(Registrant’s
Name)
Unit
E-18-01 & E-18-02, Level 18, Icon Tower (East)
No.
1, Jalan 1/68F, Jalan Tun Razak
50400
Kuala Lumpur
Wilayah
Persekutuan, Malaysia
(Address
of Principal Executive Offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Appointment
of Chief Financial Officer
On
January 5, 2026, the board of directors of Alps Group Inc (the “Company”) approved the appointment of Cheing Lye-Ping (Penny),
as the Chief Financial Officer (“CFO”) of the Company, effective January 5, 2026.
Cheing
Lye-Ping (Penny), aged 53, has over 30 years of experience in finance and accounting, including senior leadership roles in public-listed
and private companies across multiple industries. From 2014 to 2025, Ms. Cheing served as the Chief Financial Officer of a property development
company primarily involved in an integrated mixed-use development project in the city centre. From 2009 to 2013, she served as Chief
Executive Officer of Premier Asia Capital Sdn. Bhd., where she led the company’s investment strategies and managed its investment
and joint venture portfolios. From 2003 to 2008, she headed the corporate affairs department of Equine Capital Berhad, a property development
company listed on the Main Market of Bursa Malaysia. In this role, her key responsibilities included financial reporting, corporate finance,
corporate governance, risk management, and investor relations. Earlier in her career, from 1995 to 2002, she was with the audit division
of Arthur Andersen & Co, where she worked across a range of industries including manufacturing, aviation and logistics, and services.
Ms. Cheing holds a Bachelor of Business (Accountancy) from RMIT University, Australia, and a Master of Business Administration from Deakin
University, Australia. She is a Chartered Accountant registered with the Malaysian Institute of Accountants and a Fellow of CPA Australia
(FCPA).
In
connection with the appointment, Ms. Cheing entered into an executive employment agreement (the “Employment Agreement”)
with the Company setting forth the terms of her employment. Pursuant to the Employment Agreement, Ms. Cheing is entitled to an annual
base salary of $59,000, and her employment is on a fixed term of one (1) year from January 5, 2026, unless earlier terminated by either
party upon ninety (90) days’ written notice. If, Ms. Cheing’s employment is terminated by the Company without “cause”
or by Ms. Cheing for Just Cause (as defined in the Employment Agreement), she will be entitled to receive (i) accrued but unpaid base
salary through the termination date; (ii) reimbursement for any unreimbursed pre-approved reasonable business expenses incurred through
the termination date; (iii) accrued but unused annual leave days; (iv) all other payments or benefits to which she shall be entitled
as of the termination date under the terms of any applicable compensation arrangement or benefit, equity, or fringe benefit plan or program
or grant; and (v) in lieu of benefits under any severance plan or policy of the Company, any such amount as may be agreed between the
Company and Ms. Cheing.
There
are no family relationships between Ms. Cheing and any director or executive officer of the Company. To the best knowledge of the Company,
there is no understanding or arrangement between Ms. Cheing and any other person pursuant to which she was appointed.
The
Company issued a press release on January 8, 2026 announcing the appointment of the CFO, and is furnished as Exhibit 99.1.
Exhibits
| Exhibit
No. |
|
Description |
| 99.1* |
|
Press Release dated January 8, 2026 |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
Alps
Group Inc |
| |
|
|
| Date:
January 8, 2026 |
By: |
/s/
Dr. Tham Seng Kong |
| |
Name:
|
Dr.
Tham Seng Kong |
| |
Title: |
Chief
Executive Officer and Director |
Exhibit
99.1
Alps
Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer
KUALA
LUMPUR, Malaysia, January 8, 2026 - Alps Group Inc (NASDAQ: ALPS) (the “Company” or “Alps Group”), a fully integrated
biotechnology research and healthcare platform specializing in predictive, preventive, and precision medicine, today announced the appointment
of Cheing Lye-Ping (Penny) as Chief Financial Officer (CFO) of the Company, effective January 5, 2026.
Ms.
Cheing will be responsible for leading the development of the financial strategy to support the business, including investment strategies
and long-term financial plans. She will also oversee financial budgeting, planning and analysis, audit, and tax compliance for Alps Group
and subsidiaries, as well as risk management, accounting, and treasury responsibilities.
Ms.
Cheing has over 30 years of experience in finance and accounting, including senior leadership roles in public-listed and private companies
across multiple industries. Prior to joining the Company, from 2014 to 2025, Ms. Cheing served as the CFO of a property development company
primarily involved in an integrated mixed-use development project in the city centre. From 2009 to 2013, she served as Chief Executive
Officer of Premier Asia Capital Sdn. Bhd., where she led the company’s investment strategies and managed its investment and joint
venture portfolios. From 2003 to 2008, Ms. Cheing headed the corporate affairs department of Equine Capital Berhad, a property development
company listed on the Main Market of Bursa Malaysia. In this role, her key responsibilities included financial reporting, corporate finance,
corporate governance, risk management, and investor relations. Earlier in her career, from 1995 to 2002, she was with the audit division
of Arthur Andersen & Co, where she worked across a range of industries including manufacturing, aviation and logistics, and services.
Ms. Cheing holds a Bachelor of Business (Accountancy) from RMIT University, Australia, and a Master of Business Administration from Deakin
University, Australia. She is a Chartered Accountant registered with the Malaysian Institute of Accountants and a Fellow of CPA Australia
(FCPA).
Dr.
Tham Seng Kong, Chief Executive Officer of Alps Group, stated, “I am excited to welcome Penny to Alps Group’s executive leadership
team as CFO. She brings extensive experience in finance, accounting and taxation, as well as capital markets insights. We look forward
to working with her and our entire team as our business enters a new phase of exciting growth ahead.”
“I’m
honored to join Alps Group during such an important time in the Company’s evolution,” said Ms. Cheing. “The opportunity
to contribute to the work already underway is exciting, and the possibilities of what Alps Group can achieve are truly inspiring. I look
forward to partnering with not only the leadership team, but the entire company, on their journey.”
About
Alps Group
Alps
Group Inc is the parent company of Alps Life Sciences Inc, an integrated biotechnology platform integrating research and development,
medical services, and wellness solutions of advanced therapies under one unified ecosystem aimed at improving healthcare outcomes globally.
Alps Group’s mission is to promote and create a fair healthcare ecosystem by advancing predictive, preventive, and precision medicine
with the aim of improving accessibility and affordability.
Forward-Looking
Statements
Certain
statements in this press release may be considered to contain certain “forward-looking statements” within the meaning of
“safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified
by words such as: “target,” “believe,” “expect,” “will,” “shall,” “may,”
“anticipate,” “estimate,” “would,” “positioned,” “future,” “forecast,”
“intend,” “plan,” “project” and other similar expressions that predict or indicate future events
or trends or that are not statements of historical matters. Forward-looking statements are neither historical facts nor assurances of
future performance. Instead, they are based only on the Company management’s current beliefs, expectations, and assumptions. Because
forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that
are difficult to predict and many of which are outside of our control. Actual results and outcomes may differ materially from those indicated
in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.
A
further list and description of risks and uncertainties can be found in documents filed with the Securities and Exchange Commission (“SEC”)
by the Company and other documents that we may file or furnish with the SEC, which you are encouraged to read. Any forward-looking statement
made by us in this press release is based only on information currently available to the Company and speaks only as of the date on which
it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may
be made from time to time, whether as a result of new information, future developments, or otherwise, except as required by law.
Investor
Relations Contact
Andrew J. Barwicki
Tel: 516-662-9461
Email: andrew@barwicki.com
